Similarly, alterations in the TGF-β pathway—most notably the loss of TGF-β receptor II expression in lesions progressing to invasive carcinoma—reduce the growth-suppressive effects of TGF-β and promote tumor advancement [169,170,171,172,173,174,175,176,177,178]. This evidence concerns the gene TGFB1 and neoplasm.